$3.30
0.4013.79%
In chiusura: -
$3.28
-0.02-0.61%
After hour: Oct 3, 7:51 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Esperion Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
Stima EPS
$-0.020
Stima dei ricavi trimestrali
$92.94M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$268.13M
Analizza lo storico degli utili di Esperion Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics | -$0.15 | -$0.02 | — | — | $51.63M | $92.94M | — | — | 11/06/2025 | |
ESPR | Esperion Therapeutics | -$0.33 | -$0.16 | -$0.02 | 87.50% | $73.83M | $64.35M | $82.39M | 28.04% | 08/05/2025 | |
ESPR | Esperion Therapeutics | $0.34 | -$0.15 | -$0.21 | -40.00% | $137.74M | $54.19M | $65.00M | 19.94% | 05/06/2025 | |
ESPR | Esperion Therapeutics | -$0.50 | -$0.16 | -$0.11 | 31.25% | $32.25M | $61.58M | $69.11M | 12.23% | 03/04/2025 | |
ESPR | Esperion Therapeutics | -$0.37 | -$0.18 | -$0.15 | 16.67% | $33.97M | $51.32M | $51.63M | 0.61% | 11/07/2024 | |
ESPR | Esperion Therapeutics | -$0.46 | -$0.15 | -$0.05 | 66.67% | $25.79M | $50.59M | $73.83M | 45.95% | 08/12/2024 | |
ESPR | Esperion Therapeutics | -$0.79 | $0.05 | $0.34 | 580.00% | $24.33M | $84.51M | $137.74M | 62.98% | 05/07/2024 | |
ESPR | Esperion Therapeutics | -$0.76 | -$0.48 | -$0.50 | -4.17% | $18.82M | $28.70M | $32.25M | 12.37% | 02/27/2024 | |
ESPR | Esperion Therapeutics | -$0.81 | -$0.43 | -$0.37 | 13.95% | $18.98M | $29.58M | $33.97M | 14.84% | 11/07/2023 | |
ESPR | Esperion Therapeutics | -$1.05 | -$0.63 | -$0.46 | 26.98% | $18.84M | $25.50M | $25.79M | 1.12% | 08/01/2023 | |
ESPR | Esperion Therapeutics | -$0.93 | -$0.65 | -$0.79 | -21.54% | $18.84M | $22.01M | $24.33M | 10.54% | 05/09/2023 | |
ESPR | Esperion Therapeutics | -$1.77 | -$0.84 | -$0.76 | 9.52% | $15.40M | $20.85M | $18.82M | -9.75% | 02/21/2023 | |
ESPR | Esperion Therapeutics | -$2.62 | -$0.93 | -$0.81 | 12.90% | $14.41M | $19.74M | $18.98M | -3.85% | 11/01/2022 | |
ESPR | Esperion Therapeutics | -$1.67 | -$0.93 | -$1.05 | -12.90% | $40.66M | $18.71M | $18.84M | 0.70% | 08/02/2022 | |
ESPR | Esperion Therapeutics | -$3.50 | -$1.04 | -$0.93 | 10.58% | $7.98M | $15.39M | $18.84M | 22.39% | 05/03/2022 | |
ESPR | Esperion Therapeutics | -$3.89 | -$2.27 | -$1.77 | 22.03% | $9.64M | $14.47M | $15.40M | 6.43% | 02/22/2022 | |
ESPR | Esperion Therapeutics | -$3.07 | -$2.79 | -$2.62 | 6.09% | $3.83M | $12.85M | $14.41M | 12.13% | 11/02/2021 | |
ESPR | Esperion Therapeutics | $4.32 | -$1.84 | -$1.67 | 9.24% | $212.24M | $42.27M | $40.66M | -3.81% | 08/03/2021 | |
ESPR | Esperion Therapeutics | -$2.84 | -$2.52 | -$3.50 | -38.89% | $1.84M | $26.12M | $7.98M | -69.46% | 05/04/2021 | |
ESPR | Esperion Therapeutics | -$2.26 | -$3.76 | -$3.89 | -3.46% | $982.00K | $12.52M | $9.64M | -23.02% | 02/23/2021 | |
ESPR | Esperion Therapeutics | -$2.52 | -$3.41 | -$3.07 | 9.97% | $981.00K | $5.93M | $3.83M | -35.36% | 11/02/2020 |
Esperion Therapeutics (ESPR) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $-0.02 | $-0.16 | 87.5 % |
| Q1 | 2025-05-06 | $-0.21 | $-0.15 | -40.0 % |
| Q4 | 2025-03-04 | $-0.11 | $-0.16 | 31.3 % |
| Q3 | 2024-11-07 | $-0.15 | $-0.18 | 16.7 % |
Esperion Therapeutics (ESPR) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $82.39M | $64.35M | 28.0 % |
| Q1 | 2025-05-06 | $65.00M | $54.19M | 19.9 % |
| Q4 | 2025-03-04 | $69.11M | $61.58M | 12.2 % |
| Q3 | 2024-11-07 | $51.63M | $51.32M | 0.61 % |
FAQ
Quando Esperion Therapeutics (NASDAQ:ESPR) riporterà gli utili?
Si prevede che Esperion Therapeutics (ESPR) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Esperion Therapeutics (NASDAQ:ESPR)?
L'EPS effettivo era $-0.02, che superato la stima di $-0.16.
Quali sono state le entrate di Esperion Therapeutics (NASDAQ:ESPR)?
Le entrate effettive sono state $82.4M, che superato la stima di $64.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.